Clinical Trial Update: A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants [Phase 1, Phase 2]

View source ↗

Summary

This update reports a Phase 1/2a clinical trial of DB-2304 in healthy adults and participants with Systemic Lupus Erythematosus, which is currently recruiting. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• DB-2304 (DB-2304)

Snippet

Sponsor: DualityBio Inc. | Conditions: Systemic Lupus Erythematosus (SLE) | Phase 1, Phase 2 | Status: RECRUITING